RFCA
IDXX icon

R&F Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

R&F Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$755K Buy
+4,884
New +$673K 0.2% 153

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

R&F Capital Advisors's IDXX Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Idexx Laboratories (IDXX) in Q1 2017: 4,884 shares worth $755K. The stake represents 0.2% of the portfolio and ranks #153 among its holdings.

542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

  • R&F Capital Advisors held 4,884 shares of Idexx Laboratories worth $755K as of Q1 2017.
  • Idexx Laboratories was a new R&F Capital Advisors position in Q1 2017.
  • Idexx Laboratories made up 0.2% of R&F Capital Advisors's portfolio in Q1 2017, its #153 holding.
  • 542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.